However, transcriptional activation of hepatic pro-inflammatory genes remained suppressed by rivastigmine treatment regardless of hepatocyte Chrna2 deletion, suggesting this effect may occur via other nAChRs, such as CHRNA7 in KCs [15]. This evidence concerns the gene CHRNA2 and dry eye syndrome.